Kerala Ayurveda Faces Evaluation Shift Amid Mixed Technical Indicators and Weak Fundamentals
Kerala Ayurveda, a microcap in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment reflecting a shift in its technical landscape. The company reported flat performance for the quarter ending December 2024, with a notable operating loss and weak long-term fundamentals, amid mixed technical indicators.
Kerala Ayurveda, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape, moving from a mildly bullish stance to a sideways trend. The technical indicators present a mixed picture, with the MACD showing mildly bearish signals on both weekly and monthly charts, while the moving averages indicate a mildly bullish outlook on a daily basis.In terms of financial metrics, Kerala Ayurveda has reported a flat performance for the quarter ending December 2024, with a notable operating loss. The company's long-term fundamentals appear weak, highlighted by a declining operating profit growth rate and a high debt-to-equity ratio. Despite generating a return of 27.85% over the past year, the company's profitability remains low, as evidenced by its return on capital employed.
The stock's current trading position reflects a premium compared to its peers, and the technical trend suggests a lack of clear price momentum. As the company navigates these challenges, the adjustment in its evaluation underscores the complexities of its market position.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
